Functionalized lipid-based drug delivery nanosystems for the treatment of human infectious diseases

Bruna Almeida Furquim de Camargo1, Bruno Fonseca-Santos2, Suzana Gonçalves Carvalho1

  • 1School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.

Insights

Functionalized lipid-based nanocarriers offer a promising alternative for treating infectious diseases. These systems show potential against viruses, bacteria, fungi, and parasites, overcoming limitations of current antimicrobial drugs.

Area of Science:

  • Nanotechnology
  • Infectious Diseases
  • Drug Delivery Systems

Background:

  • Infectious diseases caused by viruses, bacteria, fungi, and parasites remain significant global health challenges.
  • Current treatments face limitations including side effects and the emergence of antimicrobial resistance.
  • Nanotechnology presents an alternative approach to combat these issues.

Conclusions:

  • Functionalized lipid-based DDNs represent a viable and advanced strategy for infectious disease management.
  • Nanotechnology-based drug delivery systems offer significant advantages over conventional therapies.
  • Further research into functionalized DDNs holds promise for developing novel treatments against a spectrum of pathogens.

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...